# OnCo record brain-tumours (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/brain-tumours/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "brain-tumours" ;
  schema:name "Brain and spinal cord tumours (all types)"@en ;
  schema:alternateName "Brain Tumors"@en, "Brain tumors"@en, "CNS tumours"@en, "Central nervous system tumours"@en, "Brain cancer"@en ;
  schema:description "Brain and spinal cord tumours range from slow-growing meningiomas and low-grade gliomas to glioblastoma, the commonest malignant brain tumour in adults, and a distinct set of childhood tumours such as medulloblastoma and diffuse midline glioma. Molecular markers now define them, and treatment is surgery, radiotherapy and, for some, drugs chosen by those markers."@en ;
  schema:url <https://onco.cc/cancers/brain-tumours/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Brain_tumor> ;
  schema:citation <https://www.cancer.gov/types/brain>, <https://doi.org/10.3322/caac.21660> ;
  onco:tag "umbrella" ;
  onco:related <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/dipg-dmg/>, <https://onco.cc/cancers/medulloblastoma/>, <https://onco.cc/cancers/ependymoma/>, <https://onco.cc/cancers/craniopharyngioma/>, <https://onco.cc/cancers/atrt/>, <https://onco.cc/cancers/paediatric-low-grade-glioma/>, <https://onco.cc/cancers/primary-cns-lymphoma/>, <https://onco.cc/cancers/idh-mutant-astrocytoma/>, <https://onco.cc/cancers/oligodendroglioma/>, <https://onco.cc/cancers/meningioma/>, <https://onco.cc/cancers/secondary-brain-tumours/>, <https://onco.cc/cancers/paediatric-high-grade-glioma/>, <https://onco.cc/cancers/spinal-cord-tumours/>, <https://onco.cc/cancers/vestibular-schwannoma/>, <https://onco.cc/cancers/cns-germ-cell-tumours/>, <https://onco.cc/cancers/pituitary-tumours/> ;
  onco:technologies <https://onco.cc/technologies/bbb-focused-ultrasound/> ;
  onco:targets <https://onco.cc/targets/idh/>, <https://onco.cc/targets/braf/>, <https://onco.cc/targets/mek/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/vorasidenib/>, <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/> ;
  onco:trials <https://onco.cc/trials/alliance-n0574/>, <https://onco.cc/trials/nrg-cc001/>, <https://onco.cc/trials/catnon/>, <https://onco.cc/trials/rtog-9402/>, <https://onco.cc/trials/eortc-26951/>, <https://onco.cc/trials/eortc-22033/>, <https://onco.cc/trials/nct06496971/>, <https://onco.cc/trials/nct04365374/> ;
  onco:pipeline <https://onco.cc/drugs/dordaviprone/>, <https://onco.cc/drugs/tovorafenib/>, <https://onco.cc/drugs/emavusertib/> ;
  onco:standardOfCare <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/vorasidenib/>, <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/> .